Abstract
Autophagy is a homeostatic process critical for cellular survival, and its malfunction is implicated in human diseases including neurodegeneration. Loss of autophagy contributes to cytotoxicity and tissue degeneration, but the mechanistic understanding of this phenomenon remains elusive. Here, we generated autophagy-deficient (ATG5−/−) human embryonic stem cells (hESCs), from which we established a human neuronal platform to investigate how loss of autophagy affects neuronal survival. ATG5−/− neurons exhibit basal cytotoxicity accompanied by metabolic defects. Depletion of nicotinamide adenine dinucleotide (NAD) due to hyperactivation of NAD-consuming enzymes is found to trigger cell death via mitochondrial depolarization in ATG5−/− neurons. Boosting intracellular NAD levels improves cell viability by restoring mitochondrial bioenergetics and proteostasis in ATG5−/− neurons. Our findings elucidate a mechanistic link between autophagy deficiency and neuronal cell death that can be targeted for therapeutic interventions in neurodegenerative and lysosomal storage diseases associated with autophagic defect.
Original language | American English |
---|---|
Article number | 112372 |
Journal | Cell Reports |
Volume | 42 |
Issue number | 5 |
DOIs | |
State | Published - 30 May 2023 |
Bibliographical note
Funding Information:We are grateful to R. Alagappan, A. Kaur, R. Banerjee, M. Dawlaty, Q. Gao, S. Vats, L.A. Oakey, V. Stanulovic, M. Hoogenkamp, and J. Frampton for technical assistance or providing reagents; N. Watson for electron microscopy; W. Salmon for imaging assistance; H. Salmonowicz for summary cartoon illustration; M. Coleman and S. Chakrabortee for manuscript feedback; IBR Technology Hub (at University of Birmingham; UoB), Birmingham Metabolic Tracer Analysis Core (MTAC), and Keck Microscopy Facility (at Whitehead Institute for Biomedical Research) for support and resources; ChromaDex for providing NR; and NMN Bio for providing NMN. S.S. and V.I.K. are also former fellows for life at Hughes Hall, University of Cambridge, UK. This study was mainly supported by a Wellcome Trust Seed Award (109626/Z/15/Z), Wellcome Trust ISSF (1516ISSFFEL10), a LifeArc Philanthropic Award (P2019-0004), and a Birmingham Fellowship to S.S. along with a UKIERI-DST grant (2016-17-0087) to S.S.; the FAPESP-Birmingham-Nottingham Strategic Collaboration Fund; the UoB Brazil Visiting Fellowship and Rutherford Fellowship to S.S. and T.R.R.; a BBSRC and UoB-funded MIBTP Studentship (BB/T00746X/1) to M.E.K. and S.S.; BBSRC grants (BB/R008167/2 and BB/M023389/1), a JSPS grant (18KK0242), and an MRC studentship (BH174490) to V.I.K.; grants from Emerald Foundation, St. Baldrick's Foundation, and LEO Foundation (L18015) to M.A.C. and R.J.; NIH grants (R37HD045022, R01-NS088538, and R01-MH104610) to R.J.; NIH grants (RF1AG55549 and R01-NS107265) to E.T.; FAPESP grant (2015/02041-1) to T.R.R.; funding from NIHR Surgical Reconstruction and Microbiology Research Centre in Birmingham to A.A.; fellowships from the Uehara Memorial Foundation, the International Medical Research Foundation, and JSPS (19J12969) to T.K.; a Wellcome Trust Senior Research Fellowship (217202/Z/19/Z) to E.-M.F.; a Cancer Research UK Career Development Fellowship (C53309/A19702) to O.D.K.M.; a CRUK grant (C42109/A24757) to D.A.T.; and an MRC grant (MR/P007732/1) to T.B. C.S. E.S. and S.S. designed and performed the majority of the experiments; M.A.C. M.C. J.R. D.A. A.M.P. A.A. L.S. E.G.O. T.K. P.K.P. S.L.-R. M.E.K. K.J.K. A.H.-U. M.Z. L.F.S.E.S. J.T. S.Z. G.W.H. C.W. E.R.K. D.C. S.T. E.T. G.S. Y.B. G.G.L. J.G. D.A.G. E.-M.F. T.R.R. T.B. O.D.K.M. D.A.T. H.W. R.J. and V.I.K. performed experiments, provided tools or methodologies, and/or analyzed data; S.S. V.I.K. R.J. M.A.C. T.R.R. E.T. A.A. T.K. O.D.K.M. D.A.T. and T.B. acquired funding; S.S. and V.I.K. conceptualized and administered the project; S.S. prepared the figures; S.S. and V.I.K. wrote the manuscript, and all authors contributed to and/or approved the final version. R.J. is cofounder of Fate Therapeutics, Fulcrum Therapeutics, and Omega Therapeutics and advisor to Dewpoint Therapeutics. E.S. is founder of NMN Bio Ltd. V.I.K. is a scientific advisor for Longaevus Technologies. We support inclusive, diverse, and equitable conduct of research.
Funding Information:
We are grateful to R. Alagappan, A. Kaur, R. Banerjee, M. Dawlaty, Q. Gao, S. Vats, L.A. Oakey, V. Stanulovic, M. Hoogenkamp, and J. Frampton for technical assistance or providing reagents; N. Watson for electron microscopy; W. Salmon for imaging assistance; H. Salmonowicz for summary cartoon illustration; M. Coleman and S. Chakrabortee for manuscript feedback; IBR Technology Hub (at University of Birmingham; UoB), Birmingham Metabolic Tracer Analysis Core (MTAC), and Keck Microscopy Facility (at Whitehead Institute for Biomedical Research) for support and resources; ChromaDex for providing NR; and NMN Bio for providing NMN. S.S. and V.I.K. are also former fellows for life at Hughes Hall, University of Cambridge, UK. This study was mainly supported by a Wellcome Trust Seed Award ( 109626/Z/15/Z ), Wellcome Trust ISSF ( 1516ISSFFEL10 ), a LifeArc Philanthropic Award ( P2019-0004 ), and a Birmingham Fellowship to S.S., along with a UKIERI-DST grant ( 2016-17-0087 ) to S.S.; the FAPESP - Birmingham-Nottingham Strategic Collaboration Fund; the UoB Brazil Visiting Fellowship and Rutherford Fellowship to S.S. and T.R.R.; a BBSRC and UoB -funded MIBTP Studentship ( BB/T00746X/1 ) to M.E.K. and S.S.; BBSRC grants ( BB/R008167/2 and BB/M023389/1 ), a JSPS grant ( 18KK0242 ), and an MRC studentship ( BH174490 ) to V.I.K.; grants from Emerald Foundation , St. Baldrick's Foundation , and LEO Foundation ( L18015 ) to M.A.C. and R.J.; NIH grants ( R37HD045022 , R01-NS088538 , and R01-MH104610 ) to R.J.; NIH grants ( RF1AG55549 and R01-NS107265 ) to E.T.; FAPESP grant ( 2015/02041-1 ) to T.R.R.; funding from NIHR Surgical Reconstruction and Microbiology Research Centre in Birmingham to A.A.; fellowships from the Uehara Memorial Foundation , the International Medical Research Foundation , and JSPS ( 19J12969 ) to T.K.; a Wellcome Trust Senior Research Fellowship ( 217202/Z/19/Z ) to E.-M.F.; a Cancer Research UK Career Development Fellowship ( C53309/A19702 ) to O.D.K.M.; a CRUK grant ( C42109/A24757 ) to D.A.T.; and an MRC grant ( MR/P007732/1 ) to T.B.
Publisher Copyright:
© 2023 The Author(s)
Keywords
- CP: Cell biology
- CP: Metabolism
- NAD
- NADases
- NAM
- NMN
- NR
- autophagy
- cell death
- cell survival, human embryonic stem cell-derived neurons
- mitochondria
- nicotinamide
- nicotinamide adenine dinucleotide
- nicotinamide mononucleotide
- nicotinamide riboside